Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Subscribe To Our Newsletter & Stay Updated